| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10067-017-3734-2 |
| P698 | PubMed publication ID | 28634697 |
| P50 | author | Angelo Fassio | Q88325230 |
| Luca Idolazzi | Q58348555 | ||
| P2093 | author name string | Maurizio Rossini | |
| Davide Gatti | |||
| Francesco Bertoldo | |||
| Ombretta Viapiana | |||
| Camilla Benini | |||
| Elisabetta Vantaggiato | |||
| P2860 | cites work | Classification criteria for psoriatic arthritis: development of new criteria from a large international study | Q80001900 |
| Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis | Q82357588 | ||
| High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis | Q83079558 | ||
| Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis | Q84819852 | ||
| In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density | Q86087826 | ||
| Vitamin D status in men with psoriatic arthritis: a case-control study | Q86765414 | ||
| Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma | Q28080175 | ||
| Dickkopfs and Wnt/β-catenin signalling in liver cancer | Q28391394 | ||
| Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation | Q28505419 | ||
| Prevalence and risk factors of low bone mineral density in psoriatic arthritis: A systematic review | Q30249314 | ||
| Dickkopf-1 is a key regulator of myeloma bone disease: opportunities and challenges for therapeutic intervention | Q34049686 | ||
| Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion | Q34153144 | ||
| High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients. | Q35237099 | ||
| Psoriatic arthritis: epidemiology, clinical features, course, and outcome | Q35579437 | ||
| Wnt signalling in rheumatoid arthritis | Q36037907 | ||
| Low disease activity state in rheumatoid arthritis: concepts and derivation of minimal disease activity | Q36644090 | ||
| Wnt/β-catenin signaling plays a key role in the development of spondyloarthritis | Q36717343 | ||
| Increased risk of vertebral fracture in patients with rheumatoid arthritis: A meta-analysis | Q37409538 | ||
| The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling? | Q37857468 | ||
| Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling | Q38100500 | ||
| Involvement of WNT/β-catenin signaling in the treatment of osteoporosis. | Q38113112 | ||
| Burden of disease: psoriasis and psoriatic arthritis | Q38114850 | ||
| The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study. | Q39017714 | ||
| Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro | Q40307786 | ||
| Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis. | Q41067642 | ||
| Downregulation of dickkopf-1 enhances the proliferation and osteogenic potential of fibroblasts isolated from ankylosing spondylitis patients via the Wnt/β-catenin signaling pathway in vitro | Q46278792 | ||
| Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score | Q48960736 | ||
| 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q56506042 | ||
| Sclerostin and DKK1 in Primary Hyperparathyroidism | Q58903530 | ||
| The Waning of Teriparatide Effect on Bone Formation Markers in Postmenopausal Osteoporosis Is Associated with Increasing Serum Levels of DKK1 | Q58903548 | ||
| R-spondin 1 protects against inflammatory bone damage during murine arthritis by modulating the Wnt pathway | Q61900793 | ||
| The natural disease course of ankylosing spondylitis | Q70982714 | ||
| Dickkopf-1 is a master regulator of joint remodeling | Q79610564 | ||
| P433 | issue | 10 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| psoriatic arthritis | Q511097 | ||
| P304 | page(s) | 2377-2381 | |
| P577 | publication date | 2017-06-20 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls | |
| P478 | volume | 36 |
| Q47734526 | Altered Bone Remodeling in Psoriatic Disease: New Insights and Future Directions |
| Q64079860 | Osteoimmunology of Bone Loss in Inflammatory Rheumatic Diseases |
| Q89563793 | Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis |
| Q90446547 | Role of Secreted Frizzled-Related Protein 1 and Tumor Necrosis Factor-α (TNF-α) in Bone Loss of Patients with Rheumatoid Arthritis |
| Q48283709 | The role of IL-23 receptor signaling in inflammation-mediated erosive autoimmune arthritis and bone remodeling |
Search more.